Skip to main content
PMC home page
Gut logoLink to Gut
. 1995 Mar;36(3):327–329. doi: 10.1136/gut.36.3.327

Helicobacter pylori infection does not reduce the viscosity of human gastric mucus gel.

D C Markesich 1, B S Anand 1, G M Lew 1, D Y Graham 1
PMCID: PMC1382437  PMID: 7698685

Abstract

The mechanism by which Helicobacter pylori undermines host defence mechanisms is unclear. Several in vitro studies using soluble mucins have suggested that H pylori may compromise mucus function. Gastric mucus gel was obtained from 13 H pylori infected patients; six untreated subjects and seven after eradication of the infection. Gastric mucus is a non-Newtonian substance in that its viscosity changes with changing rates of shear, requiring mucus viscosity to be measured in a rotational cone-plate microviscometer. Viscosity was measured at shear rates varying from 1.15 s-1 to 46 s-1. The gastric mucus viscosity was significantly higher in patients infected with H pylori compared with mucus gel obtained after eradication of the infection. The results of our study suggest that the previous studies using in vitro methods involving soluble mucins or its components may have lead to erroneous conclusions about the in vivo interactions of H pylori and gastric mucus gel. The present findings argue against the hypothesis that degradation of gastric mucus by H pylori is important in the pathogenesis of peptic ulcer.

Full text

PDF
327

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Curt J. R., Pringle R. Viscosity of gastric mucus in duodenal ulceration. Gut. 1969 Nov;10(11):931–934. doi: 10.1136/gut.10.11.931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Graham D. Y., Klein P. D., Evans D. J., Jr, Evans D. G., Alpert L. C., Opekun A. R., Boutton T. W. Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet. 1987 May 23;1(8543):1174–1177. doi: 10.1016/s0140-6736(87)92145-3. [DOI] [PubMed] [Google Scholar]
  3. Graham D. Y., Lew G. M., Klein P. D., Evans D. G., Evans D. J., Jr, Saeed Z. A., Malaty H. M. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med. 1992 May 1;116(9):705–708. doi: 10.7326/0003-4819-116-9-705. [DOI] [PubMed] [Google Scholar]
  4. Hansing R. L., D'Amico H., Levy M., Guillan R. A. Prediction of Helicobacter pylori in gastric specimens by inflammatory and morphological histological evaluation. Am J Gastroenterol. 1992 Sep;87(9):1125–1131. [PubMed] [Google Scholar]
  5. Hentschel E., Brandstätter G., Dragosics B., Hirschl A. M., Nemec H., Schütze K., Taufer M., Wurzer H. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med. 1993 Feb 4;328(5):308–312. doi: 10.1056/NEJM199302043280503. [DOI] [PubMed] [Google Scholar]
  6. Hui P. K., Chan W. Y., Cheung P. S., Chan J. K., Ng C. S. Pathologic changes of gastric mucosa colonized by Helicobacter pylori. Hum Pathol. 1992 May;23(5):548–556. doi: 10.1016/0046-8177(92)90132-m. [DOI] [PubMed] [Google Scholar]
  7. Murty V. L., Piotrowski J., Morita M., Slomiany A., Slomiany B. L. Inhibition of Helicobacter pylori glycosulfatase activity toward gastric sulfomucin by nitecapone. Biochem Int. 1992 May;26(6):1091–1099. [PubMed] [Google Scholar]
  8. Ormand J. A., Talley N. J. Campylobacter pylori, mucus, and peptic ulceration. A dynamic interaction. J Clin Gastroenterol. 1989 Oct;11(5):492–495. doi: 10.1097/00004836-198910000-00002. [DOI] [PubMed] [Google Scholar]
  9. Peterson W. L. Helicobacter pylori and peptic ulcer disease. N Engl J Med. 1991 Apr 11;324(15):1043–1048. doi: 10.1056/NEJM199104113241507. [DOI] [PubMed] [Google Scholar]
  10. Sarosiek J., Slomiany A., Slomiany B. L. Evidence for weakening of gastric mucus integrity by Campylobacter pylori. Scand J Gastroenterol. 1988 Jun;23(5):585–590. doi: 10.3109/00365528809093916. [DOI] [PubMed] [Google Scholar]
  11. Slomiany B. L., Bilski J., Sarosiek J., Murty V. L., Dworkin B., VanHorn K., Zielenski J., Slomiany A. Campylobacter pyloridis degrades mucin and undermines gastric mucosal integrity. Biochem Biophys Res Commun. 1987 Apr 14;144(1):307–314. doi: 10.1016/s0006-291x(87)80511-9. [DOI] [PubMed] [Google Scholar]
  12. Slomiany B. L., Murty V. L., Piotrowski J., Grabska M., Slomiany A. Glycosulfatase activity of H. pylori toward human gastric mucin: effect of sucralfate. Am J Gastroenterol. 1992 Sep;87(9):1132–1137. [PubMed] [Google Scholar]
  13. Slomiany B. L., Murty V. L., Piotrowski J., Liau Y. H., Sundaram P., Slomiany A. Glycosulfatase activity of Helicobacter pylori toward gastric mucin. Biochem Biophys Res Commun. 1992 Mar 16;183(2):506–513. doi: 10.1016/0006-291x(92)90511-i. [DOI] [PubMed] [Google Scholar]
  14. Slomiany B. L., Sarosiek J., Liau Y. H., Laszewicz W., Slomiany A. Lysolecithin affects the viscosity, permeability, and peptic susceptibility of gastric mucin. Scand J Gastroenterol. 1986 Nov;21(9):1073–1079. doi: 10.3109/00365528608996423. [DOI] [PubMed] [Google Scholar]
  15. Slomiany B. L., Slomiany A. Mechanism of Helicobacter pylori pathogenesis: focus on mucus. J Clin Gastroenterol. 1992;14 (Suppl 1):S114–S121. [PubMed] [Google Scholar]
  16. Thomsen L. L., Gavin J. B., Tasman-Jones C. Relation of Helicobacter pylori to the human gastric mucosa in chronic gastritis of the antrum. Gut. 1990 Nov;31(11):1230–1236. doi: 10.1136/gut.31.11.1230. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES